|
BR9813465A
|
|
Modified polysaccharides that exhibit altered biological recognition
|
|
WO9820905A2
|
|
Treatment of iron overload disorders
|
|
US5847110A
|
|
Method of reducing a schiff base
|
|
EP0901521A1
|
|
Antigenic modulation of cells
|
|
US5268165A
|
|
Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
|
|
CA2094028A1
|
|
Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
|
|
US5217998A
|
|
Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
|
|
EP0523037A1
|
|
Fluid resuscitation
|
|
AU5643490A
|
|
Fluid resuscitation
|
|
US5416078A
|
|
Fluid resuscitation
|
|
US4863964A
|
|
Method for the stabilization of deferoxamine to chelate free ions in physiological fluid
|
